The Trump administration is attempting to change the way we all pay for prescription drugs.
This year, Health and Human Services Secretary Alex Azar announced a new rule that would get rid of one of the least transparent parts of drug pricing: Giving rebates to middlemen known as pharmacy benefit managers.
The Trump administration said the move will lower prescription prices for consumers, but others say it will simply shift costs around.
Brendon Blake, senior program administrator with AARP Arizona, joined The Show to talk about this new rule and why AARP thinks it could hurt seniors.
